CD32-mediated suppression of plasma cells in patients with multiple myeloma.
Ross
Brown
B
Institute of Haematology Royal Prince Alfred Hospital, Sydney, Australia. ross.brown@email.cs.nsw.gov.au
D018941:Antigens, CD19 / Q000235:genetics / Q000502:physiology; D006801:Humans; D009101:Multiple Myeloma / Q000473:pathology*; D010950:Plasma Cells / Q000473:pathology*; D017452:Receptors, IgG / Q000502:physiology*
D018941:Antigens, CD19; D017452:Receptors, IgG